Investors
A multi‑company group with a long‑term view.
Celavista is a multi‑company group spanning pharmaceutical molecules, nature‑based health products, climate technology, ophthalmology and healthy ageing. We welcome conversations with investors who share our long‑term view. Information is provided on request and, where appropriate, under a non‑disclosure agreement.
What each company is looking for
- AIRCURETECHStrategic and industrial partners, and investment to fund prototypes, facilities and field demonstrations. Open to U.S. investors only.
- AIONSIGHTClinical and research partners across several continents for the next 12 to 18 months; patent filings and advanced clinical studies in preparation.
- MITO‑BIOGENESISManufacturing and licensing partners for Celavista molecules; distribution partners in the United States and across the Americas, with regional rights available.
- CELAVISTA CHINAPartners worldwide in neuro‑ophthalmology and in ageing and longevity, to shape the 2027 project from its earliest stages.
- THE GROUPConversations with investors who share a long‑term view of science from nature.
The information on this website does not constitute an offer to sell or a solicitation of an offer to buy any securities.
Contact
Investor relations: info@celavista.com